Protara Therapeutics, Inc. Increase (Decrease) in Accounts Payable
Protara Therapeutics, Inc. (TARA) reported Increase (Decrease) in Accounts Payable of $1.33 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-11
- Protara Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $243.00K, a 91.87% decline year-over-year.
- Protara Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $1.09M.
- Protara Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$1.56M, a 202.76% decline year-over-year.
- Protara Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$795.00K, a 187.36% decline year-over-year.
- Protara Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2025 was -$873.00K, a 163.22% decline from fiscal 2024.
- Protara Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2024 was $1.38M, a 62.85% increase from fiscal 2023.
- Protara Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2023 was $848.00K, a 34.39% increase from fiscal 2022.
- Protara Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2022 was $631.00K, a 1477.50% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $243.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.33M 10-Q · filed 2026-08-11 | -$230.00K derived: sum of 3 quarters · filed 2026-08-11 | -$1.02M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2026-03-31 | $1.09M 10-Q · filed 2026-05-13 | -$473.00K derived: sum of 2 quarters · filed 2026-05-13 | -$1.27M derived: sum of 3 quarters · filed 2026-05-13 | $1.72M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-12-31 | -$1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$2.36M derived: sum of 2 quarters · filed 2026-03-10 | $631.00K derived: sum of 3 quarters · filed 2026-08-11 | -$873.00K 10-K · filed 2026-03-10 | |||
| 2025-09-30 | -$795.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $2.19M derived: sum of 2 quarters · filed 2026-08-11 | $689.00K 10-Q · filed 2025-11-10 | $2.21M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-06-30 | $2.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.48M 10-Q · filed 2026-08-11 | $3.00M derived: sum of 3 quarters · filed 2026-08-11 | $3.91M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-03-31 | -$1.50M 10-Q · filed 2026-05-13 | $16.00K derived: sum of 2 quarters · filed 2026-05-13 | $926.00K derived: sum of 3 quarters · filed 2026-05-13 | $1.34M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $2.43M derived: sum of 2 quarters · filed 2026-03-10 | $2.84M derived: sum of 3 quarters · filed 2026-03-10 | $1.38M 10-K · filed 2026-03-10 | |||
| 2024-09-30 | $910.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.32M derived: sum of 2 quarters · filed 2025-11-10 | -$139.00K 10-Q · filed 2025-11-10 | -$209.00K derived: sum of 4 quarters · filed 2025-11-10 | |||
| 2024-06-30 | $413.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$1.05M 10-Q · filed 2025-08-11 | -$1.12M derived: sum of 3 quarters · filed 2025-08-11 | -$467.00K derived: sum of 4 quarters · filed 2025-08-11 | |||
| 2024-03-31 | -$1.46M 10-Q · filed 2025-05-08 | -$1.53M derived: sum of 2 quarters · filed 2025-05-08 | -$880.00K derived: sum of 3 quarters · filed 2025-05-08 | -$3.11M derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | -$70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $582.00K derived: sum of 2 quarters · filed 2025-03-05 | -$1.65M derived: sum of 3 quarters · filed 2025-03-05 | $848.00K 10-K · filed 2025-03-05 | |||
| 2023-09-30 | $652.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$1.58M derived: sum of 2 quarters · filed 2024-11-12 | $918.00K 10-Q · filed 2024-11-12 | $2.05M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | -$2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $266.00K 10-Q · filed 2024-08-06 | $1.40M derived: sum of 3 quarters · filed 2024-08-06 | $1.46M derived: sum of 4 quarters · filed 2024-08-06 | |||
| 2023-03-31 | $2.50M 10-Q · filed 2024-05-02 | $3.62M derived: sum of 2 quarters · filed 2024-05-02 | $3.69M derived: sum of 3 quarters · filed 2024-05-02 | $3.54M derived: sum of 4 quarters · filed 2024-05-02 | |||
| 2022-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $1.19M derived: sum of 2 quarters · filed 2024-03-13 | $1.04M derived: sum of 3 quarters · filed 2024-03-13 | $631.00K 10-K · filed 2024-03-13 | |||
| 2022-09-30 | $64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$85.00K derived: sum of 2 quarters · filed 2023-11-03 | -$498.00K 10-Q · filed 2023-11-03 | -$472.00K derived: sum of 4 quarters · filed 2023-11-03 | |||
| 2022-06-30 | -$149.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$562.00K 10-Q · filed 2023-08-03 | -$536.00K derived: sum of 3 quarters · filed 2023-08-03 | -$1.01M derived: sum of 4 quarters · filed 2023-08-03 | |||
| 2022-03-31 | -$413.00K 10-Q · filed 2023-05-04 | -$387.00K derived: sum of 2 quarters · filed 2023-05-04 | -$862.00K derived: sum of 3 quarters · filed 2023-05-04 | -$1.31M derived: sum of 4 quarters · filed 2023-05-04 | |||
| 2021-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | -$449.00K derived: sum of 2 quarters · filed 2023-03-08 | -$898.00K derived: sum of 3 quarters · filed 2023-03-08 | $40.00K 10-K · filed 2023-03-08 | |||
| 2021-09-30 | -$475.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$924.00K derived: sum of 2 quarters · filed 2022-11-03 | $14.00K 10-Q · filed 2022-11-03 | -$985.00K derived: sum of 4 quarters · filed 2022-11-03 | |||
| 2021-06-30 | -$449.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $489.00K 10-Q · filed 2022-08-09 | -$510.00K derived: sum of 3 quarters · filed 2022-08-09 | $487.00K derived: sum of 4 quarters · filed 2022-08-09 | |||
| 2021-03-31 | $938.00K 10-Q · filed 2022-05-05 | -$61.00K derived: sum of 2 quarters · filed 2022-05-05 | $936.00K derived: sum of 3 quarters · filed 2022-05-05 | -$798.00K derived: sum of 4 quarters · filed 2022-05-05 | |||
| 2020-12-31 | -$999.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | -$2.00K derived: sum of 2 quarters · filed 2022-03-09 | -$1.74M derived: sum of 3 quarters · filed 2022-03-09 | $198.00K 10-K · filed 2022-03-09 | |||
| 2020-09-30 | $997.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$737.00K derived: sum of 2 quarters · filed 2021-11-04 | $1.20M 10-Q · filed 2021-11-04 | $1.20M 10-Q · filed 2020-11-12 | $1.72M derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2020-06-30 | -$1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $200.00K 10-Q · filed 2021-08-05 | $199.55K 10-Q · filed 2020-07-31 | $718.24K derived: sum of 3 quarters · filed 2021-08-05 | $645.25K derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | $1.93M 10-Q · filed 2021-05-06 | $1.93M 10-Q · filed 2020-05-13 | $2.45M derived: sum of 2 quarters · filed 2021-05-06 | $2.38M derived: sum of 3 quarters · filed 2021-05-06 | $2.45M derived: sum of 4 quarters · filed 2021-05-06 | ||
| 2019-12-31 | $518.24K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $445.25K derived: sum of 2 quarters · filed 2021-03-11 | $512.69K derived: sum of 3 quarters · filed 2021-03-11 | $366.00K 10-K · filed 2021-03-11 | |||
| 2019-09-30 | -$72.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$5.55K derived: sum of 2 quarters · filed 2020-11-12 | -$152.24K 10-Q · filed 2020-11-12 | ||||
| 2019-06-30 | $67.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | -$79.25K 10-Q · filed 2020-07-31 | |||||
| 2019-03-31 | -$146.69K 10-Q · filed 2020-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |